MYLAN-CLONAZEPAM
MYLAN-CLONAZEPAM
Discontinued
DIN Number
02230951
Drug Class
Human
Market Date
Mar 20, 1997
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230951
AIG Number0111558002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N03AE01 CLONAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLONAZEPAMActive
Strength: 2 MG
Monograph: CLONAZEPAM